Abstract
Hyperlipidemia has been recognized in patients with renal disease for over a century. Only with the advent of dialysis treatment, however, has it been possible to determine why, in some chronically uremic patients, large lightscattering triglyceride-rich fat particles may accumulate in sufficient numbers to cause plasma lactes cence.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brunzell JD, Albers J J, Haas LB, Goldberg AP, Agadoa L, Sherrard DJ: Prevalence of serum lipid abnormalities in chronic hemodialysis. Metabolism 26: 903, 1977
Bagdade JD, Casaretto A, Albers J J: Effects of chronic uremia, hemodialysis and renal transplantation on plasma lipids and lipoproteins in man. J Lab Clin Med 87: 37, 1976
Daubresse JC, Lerson G, Plomteux G, Rorive G, Luycks AS, Lefebvre PJ: Lipids and lipoproteins in chronic uraemia: a study of the influences of regular haemodialysis. Eur J Clin Invest 6: 159, 1976
Ibels LS, Simons LA, King JO, Williams PF, Neale FC, Stewart JH: Studies on the nature and causes of hyperlipi- daemia in uraemia, maintenance dialysis and renal transplantation. Q J Med 44: 601, 1975
Bagdade JD, Albers JJ: Plasma high density lipoprotein concentrations in chronic hemodialysis and renal transplant patients. N Engl J Med 296: 1436, 1977
Minamisono T, Wada M, Akamutsu A, Okabe M, Handa Y, Morita T, Asagami C, Naito HK, Nakamoto S, Lewis LA, Mise J: Dyslipoproteinemia (a remnant lipoprotein disease) in uremic patients on hemodialysis. Clin Chim Acta 84: 163, 1978
Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ: HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation 55: 767, 1977
Miller GJ, Miller NE r Plasma high density lipoprotein concentration and development of ischaemic heart disease. Lancet 1: 16, 1975
Bagdade JD, Porte D Jr, Bierman EL: Hypertriglyceridemia: a metabolic consequence of chronic renal failure. N Engl J Med 269: 181, 1968
Cattran DC, Fenton SA, Wilson DR, Steiner G: Defective triglyceride removal in lipemia associated with peritoneal dialysis and hemodialysis. Ann Intern Med 85: 29, 1976
Bagdade JD, Yee E, Shafrir E, Wilson DE: Hyperlipidemia in renal failure: studies of plasma lipoproteins, hepatic triglyceride production and tissue lipoprotein lipase in a chronically uremic rat model. Metabolism 25: 533, 1977
Mako M, Block M, Starr J, Nielsen E, Friedman EA, Rubenstein A: Proinsulin in chronic renal and hepatic failure: a reflection of the relative contribution of the liver and the kidney to its metabolism. Clin Res 21:631 A, 1973
Mordasini R, Frey F, rlury W, Klose G, Greten H: Selective deficiency of hepatic triglyceride lipase in uremic patients. N Engl J Med 297: 1362, 1977
Appelbaum-Bowden D, Goldberg AP, Hazzard WR, Sherrard DJ, Brunzell JD, Huttunen JK, Nikkila EA, Ehnholm C: Postheparin plasma triglyceride lipase in chronic hemodialysis: evidence for a role of hepatic lipase in lipoprotein metabolism. Metabolism 28: 917, 1979
Goldberg AP, Sherrard DJ, Brunzell JD: Adipose tissue lipoprotein lipase in chronic hemodialysis: Role in plasma triglyceride metabolism. J Clin Endocrinol Metab 47: 1173, 1978
Rapoport J, Aviram M, Chaimovitz C, Brook JG: Defective high-density lipoprotein composition in patients on chronic hemodialysis. New Engl J Med 299: 1326, 1978
Bohmer T, Bergrem H, Eiklid K: Carnitine deficiency induced during intermittent haemodialysis for renal failure. Lancet 1: 126, 1978
Lacour B, DiGiulio S, Chanard J, Ciancioni C, Haguet M, Lebkiri B, Basile C, Drueke T, Assan R, Funck-Brentano J-L: Carnitine improves lipid abnormalities in haemodialysis patients. Lancet 2: 763, 1980
Choi ESK, Chung T, Morrison R, Meyers C, Greenberg M: Hypertriglyceridemia in hemodialysis patients during oral dromostanolone therapy for anemia. Am J Clin Nutr 27: 901, 1974
Glueck CJ, Scheel D, Fishback J, Steiner R: Progestasteg- ens, anabolic-androgenic compounds, estrogens: effects on triglycerides and post heparin lipolytic enzymes. Lipids 7: 110, 1972
Bagdade JD, Livingston R, Yee E: Effects of the synthetic androgen fluoxymesterone on triglyceride secretion rates in the rat. Proc Soc Exp Biol Med 149: 452, 1975
Davidson WD, Morin RJ, Rorke SJ, Guo LSS: The role of acetate in dialysate for hemodialysis. Proc 10th Annu Contr ConfArtif Kidney Progr NIAMDD DHEW edited by Mackey BB, publ no (NIH) 77–1442, 1977, p 15
Wathen RL, Keshaviah P, Comty C: Acid-base regulation in hemodialysis. Proc 10th Annu Contr Conf Artif Kidney Progr NIAMDD DHEW edited by Mackey BB, publ no (NIH) 77-1442, 1077, p 17
Basta LL, Williams C, Kioschos JM, Spector AA: Regression of atherosclerotic stenosing lesions of the renal arteries and spontaneous cure of systemic hypertension through control of hyperlipidemia. Am J Med 61: 420, 1976
Haire H, Sherrard D, Scardapane D, Curtis FK, Brunzell JD: Smoking, hypertension and mortality in a maintenance dialysis population. Cardiovasc Med 3: 1163, 1978
Wahlqvist ML, Hurley BP: Hyperliproproteinemia and dietary fat modification in hemodialysis and renal transplant patients. Med J Aust 2: 207, 1977
Zilversmit DB: Atherogenesis: A postprandial phenomenon. Circulation 60: 473, 1979
Castelli WP, Doyle JT, Gordon T, Harnes CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ: Alcohol and blood lipids: The cooperative lipoprotein phenotyping study. Lancet 2: 153, 1977
Goldberg AP, Sherrard D, Haas L, Brunzell JD: Control of Clofibrate toxicity in the treatment of uremic hypertriglyceridemia. Clin Pharmacol Ther 21: 314, 1977
Goldberg AP, Appelbaum-Bowden DM, Bierman EL, Haz- zard WR, Haas LB, Sherrard DJ, Brunzell JD, Huttunen JK, Ehnholm C, Nikkila EA: Increase in lipoprotein lipase during Clofibrate treatment of hypertriglyceridemia in patients on hemodialysis. N Eng J Med 301: 1073, 1979
A cooperative trial in the primary prevention of ischaemic heart disease using Clofibrate. Report from the Committee of Principal Investigators. Brit Heart J 40: 1069, 1978
Goldberg AP, Hagberg J, Delmez JA, Haynes ME, Harter HR: Metabolic effects of exercise training in hemodialysis patients. Kidney Int 18: 754, 1980
Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance dialysis. New Engl J Med 290: 697, 1974
Cameron JS, Ellis FG, Ogg CS, Bewich M, Boulton-Jones JM, Robinson RD, Harrison J: A comparison of mortality and rehabilitation in regular dialysis and transplantation. Proc Eur Dial Transpl Assoc 7: 25, 1970
Rostrand SG, Gretes JC, Kirk KA, Rutsky EA, Andreoli JE: Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int 16: 600, 1979
Nicholls AJ, Catto GR, Edward N, Engeset J, Macleod M: Accelerated atherosclerosis in long-term dialysis and renal transplant patients: fact or fiction. Lancet 1: 276, 1980
Editorial (anonymous): Cardiovascular risks and oral contraceptives. Lancet 1: 1063, 1979
Ross R, Glomset JA: The pathogenesis of atherosclerosis. N Engl J Med 295:369 and 420, 1976
Craddock PR, Fehr J, Dalmasso AP, Brigham KL, Jacob HS: Hemodialysis leukopenia: pulmonary vascular leuko- stasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 59: 879, 1977
George CR, Slichter SJ, Quadracci LJ, Striker GE, Harker LA: A kinetic evaluation of hemostasis in renal disease. N EngJMed 291: 1111, 1974
Bagdade JD: Chronic renal failure and atherogenesis: serum factors stimulate the proliferation of human arterial smooth muscle cells. Atherosclerosis 34: 243, 1979
Guzzo J, Niewiarowski S, Musial J, Bastl C, Grossman RA, Rao AK, Berman I, Paul D: Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure. J Lab Clin Med 96: 102, 1980
Bagdade JD, Subbaiah PV, Bartos D, Bartos F, Campbell RA: Polyamines: an unrecognized cardiovascular risk factor in chronic dialysis? Lancet 1: 412, 1979
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Martinus Nijhoff Publishers, Dordrecht
About this chapter
Cite this chapter
Bagdade, J.D. (1983). Hyperlipidemia and Atherosclerosis in Chronic Dialysis Patients. In: Drukker, W., Parsons, F.M., Maher, J.F. (eds) Replacement of Renal Function by Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6768-7_29
Download citation
DOI: https://doi.org/10.1007/978-94-009-6768-7_29
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-89838-770-4
Online ISBN: 978-94-009-6768-7
eBook Packages: Springer Book Archive